Tejnaksh Healthcare Limited

BSE: TEJNAKSH539428ISIN INE030T01027

Healthcare
Healthcare Service Provider

Share price

₹12.83+0.33 (+2.64%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹18.60
52W low: ₹10.65
Off 52W high: -31.02%
1M return: +5.08%
3M return: -3.46%
6M return: -19.76%
1Y return: -27.02%
20D avg volume: 7,167
50 DMA: ₹13.11
200 DMA: ₹14.03

Key ratios Consolidated

Market cap: ₹26.06 Cr
Current price: ₹12.83
52W high / low: ₹18.60 / ₹10.65
Face value: ₹5.00
P/E: 21.19
P/B: 0.96
EPS (TTM): ₹0.61
Book value / share: ₹13.36
ROE: —
ROCE: 5.90%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-1.95 Cr
Interest cover: 17.50
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 93.7 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	2.65	2.55	2.62	2.98	2.64	3.21	3.19	3.37	3.12	—
	0.10	0.14	0.07	0.09	0.09	0.07	0.17	0.09	0.07	—
	2.75	2.69	2.69	3.07	2.73	3.29	3.36	3.45	3.20	—
	2.33	2.17	2.33	2.59	2.45	2.69	2.40	2.62	2.40	—
	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.01	0.01	—
	0.30	0.24	0.25	0.28	0.25	0.29	0.60	0.04	0.31	—
	0.29	0.31	0.33	0.41	0.34	0.39	0.44	0.34	0.35	—
	0.01	-0.03	0.04	0.03	0.05	0.01	0.14	0.11	0.12	—
	0.35	0.36	0.36	0.35	0.36	0.17	0.20	0.31	0.23	—
	1.43	1.31	1.34	1.51	1.44	1.73	1.04	1.89	1.35	—
	0.42	0.52	0.36	0.49	0.28	0.59	0.97	0.83	0.80	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.42	0.52	0.36	0.49	0.28	0.59	0.97	0.83	0.80	—
	0.16	0.17	0.07	0.15	0.07	0.17	0.41	0.18	0.20	—
	0.26	0.35	0.29	0.33	0.21	0.42	0.56	0.65	0.60	—
	0.13	0.17	0.14	0.15	0.12	0.21	0.38	0.31	0.29	—
Key metrics
	0.78	0.85	0.76	0.87	0.69	0.77	1.31	1.25	1.15	—
	29.40%	33.30%	29.00%	29.20%	26.10%	24.00%	41.10%	37.10%	36.90%	—
	9.80%	13.70%	11.10%	11.10%	8.00%	13.10%	17.60%	19.30%	19.20%	—
	—	1.70%	—	1.80%	—	2.10%	—	—	—	—
	0.40%	-20.60%	-17.90%	-11.60%	-15.40%	—	—	—	—	—
	23.80%	-16.70%	-48.20%	-49.20%	-65.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	10.80	10.79	12.90	—
	0.40	0.39	0.40	—
	11.20	11.18	13.30	—
	9.42	9.53	10.11	—
	0.04	0.05	0.00	—
	1.07	1.02	1.25	—
	1.34	1.39	1.53	—
	0.05	0.10	0.38	—
	1.42	1.43	0.91	—
	5.59	5.60	6.01	—
	1.79	1.65	3.19	—
	0.00	0.00	0.00	—
	1.79	1.65	3.19	—
	0.55	0.47	0.96	—
	1.23	1.18	2.23	—
	0.59	0.61	1.15	—
Key metrics
	3.26	3.18	4.48	—
	30.19%	29.50%	34.70%	—
	11.39%	10.90%	17.30%	—
	—	5.90%	12.20%	—
	-12.97%	-16.40%	—	—
	-33.15%	-47.10%	—	—
	—	1.21	0.13	—
	—	1.46	0.17	—
	—	0.00	0.02	—
	—	-1.95	-1.13	—
	—	93.7	66.2	—
Balance sheet
	—	30.05	30.31	—
	—	5.30	5.92	—
	—	1.95	1.76	—
	—	2.18	1.85	—
	—	0.83	0.79	—
	—	—	1.25	—
	—	18.29	19.05	—
	—	0.24	0.30	—
	—	0.63	1.09	—
	—	0.00	0.63	—
	—	0.00	0.00	—
	—	0.00	0.63	—
	—	27.64	26.45	—
Cash flow
	—	1.72	0.38	—
	—	-0.28	3.52	—
	—	-1.24	-3.87	—
	—	0.51	0.25	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	1.84	1.77	1.69	1.94	1.78	2.40	2.24	1.98	2.18	—
	0.09	0.15	0.06	0.08	0.08	0.06	0.14	0.08	0.07	—
	1.93	1.92	1.75	2.02	1.86	2.47	2.38	2.06	2.25	—
	1.48	1.30	1.45	1.59	1.41	1.43	1.16	1.43	1.46	—
	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.01	0.01	—
	0.14	0.12	0.09	0.11	0.12	0.14	0.07	0.20	0.16	—
	0.15	0.15	0.18	0.26	0.18	0.22	0.17	0.18	0.20	—
	0.01	0.01	0.04	0.04	0.04	0.04	0.11	0.11	0.12	—
	0.33	0.33	0.33	0.33	0.33	0.15	0.17	0.27	0.20	—
	0.88	0.77	0.70	0.83	0.79	0.82	0.64	0.72	0.73	—
	0.45	0.62	0.30	0.42	0.45	1.04	1.21	0.63	0.78	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.45	0.62	0.30	0.42	0.45	1.04	1.21	0.63	0.78	—
	0.16	0.11	0.07	0.11	0.11	0.28	0.49	0.07	0.20	—
	0.29	0.50	0.23	0.31	0.34	0.75	0.72	0.57	0.59	—
	0.14	0.39	0.11	0.15	0.17	0.37	0.36	0.31	0.29	—
Key metrics
	0.79	0.96	0.67	0.79	0.82	1.23	1.49	1.01	1.10	—
	42.90%	54.20%	39.60%	40.70%	46.10%	51.30%	66.50%	51.00%	50.50%	—
	15.80%	28.20%	13.60%	16.00%	19.10%	31.20%	32.10%	28.80%	27.10%	—
	—	2.20%	—	1.60%	—	3.80%	—	—	—	—
	3.40%	-26.20%	-24.60%	-2.00%	-18.30%	—	—	—	—	—
	-14.70%	-33.30%	-68.10%	-45.60%	-42.40%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	7.24	7.18	8.80	—
	0.38	0.37	0.35	—
	7.62	7.55	9.15	—
	5.82	5.77	5.49	—
	0.04	0.05	0.00	—
	0.46	0.44	0.57	—
	0.74	0.78	0.77	—
	0.10	0.13	0.38	—
	1.32	1.31	0.79	—
	3.18	3.09	2.90	—
	1.79	1.79	3.66	—
	0.00	0.00	0.00	—
	1.79	1.79	3.66	—
	0.45	0.41	1.04	—
	1.33	1.38	2.62	—
	0.79	0.68	1.29	—
Key metrics
	3.21	3.23	4.83	—
	44.34%	45.00%	54.90%	—
	18.37%	19.20%	29.80%	—
	—	6.70%	14.30%	—
	-13.81%	-18.40%	—	—
	-44.12%	-47.30%	—	—
	—	1.28	0.30	—
	—	1.30	0.18	—
	—	0.00	0.02	—
	—	-1.86	-0.98	—
	—	116.9	81.7	—
Balance sheet
	—	29.22	29.00	—
	—	4.44	4.95	—
	—	1.86	1.61	—
	—	2.02	1.75	—
	—	0.39	0.37	—
	—	—	1.15	—
	—	17.38	18.02	—
	—	0.11	0.15	—
	—	0.40	0.83	—
	—	0.00	0.63	—
	—	0.00	0.00	—
	—	0.00	0.63	—
	—	26.80	25.41	—
Cash flow
	—	1.79	0.48	—
	—	-0.41	3.58	—
	—	-1.20	-3.86	—
	—	0.51	0.18	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -13.81%
Profit YoY (TTM): -44.12%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -12.97%
Profit YoY (TTM): -33.15%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 73.83%

Quarter	September 2026	June 2026
Promoter %	73.83%	73.83%

Holder	Type	Holding	Previous	Change
ASHISH VISHWAS RAWANDALE	Promoter	38.15%	38.15%	0.00%
PREETI ASHISH RAWANDALE	Promoter Group	35.53%	35.53%	0.00%
SHEETAL UTKARSH RAWANDALE	Public	1.45%	1.45%	0.00%
SONAL LOHIA	Public	1.35%	1.35%	0.00%
VARUN MAHAJAN	Public	1.03%	—	—
PRAMILA VISHWASRAO PATIL	Promoter	0.15%	0.15%	0.00%
UTKARSH VISHWAS RAWANDALE	Promoter	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Dr. Lal Pathlabs Limited	34,056	2,028.95	57.92	25.70%	+16.71% TTM	+8.93% TTM	+28.73%
Vijaya Diagnostic Centre Limited	14,676	1,424.85	72.05	19.20%	+24.48% TTM	+33.96% TTM	+39.02%
Metropolis Healthcare Limited	12,075	582.05	53.57	15.70%	+19.84% TTM	+41.90% TTM	+14.58%
Thyrocare Technologies Limited	7,883	495.25	55.01	33.60%	+21.99% TTM	+13.16% TTM	+9.41%
Nephrocare Health Services Limited	6,242	620.75	48.72	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,735	333.10	49.46	14.70%	+23.32% TTM	+7.94% TTM	+2.54%
Krsnaa Diagnostics Limited	1,566	482.90	15.97	10.60%	+15.90% TTM	+16.02% TTM	-37.25%
3B BlackBio Dx Limited	1,142	1,330.25	20.29	22.60%	+54.30% TTM	+14.75% TTM	-1.52%
HEALTH X PLATFORM LIMITED	863	271.20	-33.11	—	+28.85% TTM	+82.45% TTM	-8.73%
ONE GLOBAL SERVICE PROVIDER LIMITED S	861	440.70	11.65	65.70%	+161.55% TTM	+178.28% TTM	+21.17%
Gaudium IVF and Women Health Limited	779	107.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited S	144	140.35	-318.98	2.90%	+14.50% TTM	-117.58% TTM	+132.68%
Choksi Laboratories Ltd. S	142	203.90	65.77	12.30%	+10.74% TTM	+44.00% TTM	+38.05%
STAR IMAGING AND PATH LAB LIMITED	120	68.90	—	22.60%	—	—	-51.78%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	86	57.00	—	11.20%	—	—	—
Sharma East India Hospitals And Res S	34	87.05	24.11	14.20%	+14.13% TTM	-9.85% TTM	-38.28%
BANDARAM PHARMA PACKTECH LIMITED	34	19.03	25.81	4.70%	+114.59% TTM	+454.17% TTM	-22.14%
N.G.Industries Ltd. S	34	100.00	17.39	6.30%	+2.18% TTM	-74.06% TTM	-23.28%
Deccan Health Care Limited	29	12.00	11.40	3.20%	-0.37% TTM	+145.63% TTM	-29.41%
Chennai Meenakshi Multispeciality Hospital Ltd. S	27	36.78	-32.26	-2.80%	+0.08% TTM	+6.59% TTM	-29.27%
SAMSRITA LABS LIMITED	27	11.93	-3.33	-73.40%	—	—	-43.35%
Tejnaksh Healthcare Limited	26	12.83	21.19	5.90%	-12.97% TTM	-33.15% TTM	-27.02%
Transgene Biotek Ltd.	17	2.57	-12.11	-0.50%	-14.81% TTM	-23.85% TTM	-28.21%
Dolphin Medical Services Ltd. S	11	7.11	59.25	0.60%	-1.25% TTM	+700.00% TTM	+246.83%
Looks Health Services Limited S	11	10.08	504.00	0.20%	-41.89% TTM	-57.14% TTM	+101.20%

Filings & corporate actions

Recent announcements

Respected Sir/Madam, Please find attached the letter for your reference and record Thanks2 Nov 2026 · Company Update / General
Respected Madam/Sir, Please find attached letter. Thanks & Regards24 Oct 2026 · Company Update / General
Respected Sir/Madam, Please refer attached 74(5) Certificate for your reference. Thanks & Regards24 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Respected Madam/Sir, Please find attached Reappointment of Independent Director Suhas Thorat for the second term.1 Oct 2026 · Company Update / Change in Management
Respected Madam/Sir, Please find attached Scrutinizer Report.1 Oct 2026 · AGM/EGM / AGM
Please refer letter attached for AGM proceeding held on 29th September 202629 Sep 2026 · AGM/EGM / AGM
Respected Sir/Madam, Please refer attached closure of trading window intimation.26 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Dear Sir / Madam With reference to captioned subject find enclosed herewith Annual Report of the Company for the F.Y. 2025-26 Kindly take the same on your record.4 Sep 2026 · Others / Reg. 34 (1) Annual Report
This to inform that the 19th Annual General meeting to be held on 29th September 2026. Notice is attached for your reference4 Sep 2026 · AGM/EGM / AGM
Please find attached unaudited FS as of June 2613 Aug 2026 · Result / Financial Results
In continuation of our Letter dated 08th August, 2026 we wish to inform you that a meeting oft he Board of Directors of the Company was held on Thursday, 13th August, 2026 at 03:00 pm ....13 Aug 2026 · Board Meeting / Outcome of Board Meeting
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve We hereby inform you that ....8 Aug 2026 · Board Meeting / Board Meeting
Respected Sir/Madam, Please compliance certificate under Reg. 74(5) of SEBI(DP) Reg 2018.19 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please refer attached closure of trading window.25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Please find enclosed Annual Secretarial Report for the Financial year 2025-2630 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Please find enclosed Audited financial results for March 202630 May 2026 · Result / Financial Results
1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2026, and Auditors Report thereon;2. A declaration pursuant to ....30 May 2026 · Board Meeting / Outcome of Board Meeting
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....20 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....28 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Respected Sir/Madam, Please refer Certificate under Reg.74(5) of SEBI(DP) Regulation.21 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Respected Sir/Madam, Please find our reply attached below.9 Apr 2026 · Company Update / General
The Exchange has sought clarification from Tejnaksh Healthcare Ltd on April 8, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....8 Apr 2026 · Company Update / Clarification
Please refer closure of trading window reference.27 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Please refer standalone and consolidated unaudited result for the quarter ended 31st December 2025.7 Feb 2026 · Result / Financial Results
In continuation of our Letter dated 2th February, 2026 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday, 7th February, 2026 at Shop No 1 ....7 Feb 2026 · Board Meeting / Outcome of Board Meeting
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Pursuant to Regulation ....2 Feb 2026 · Board Meeting / Board Meeting
Respected Sir/Madam, Please refer letter attached for your reference. Thanks Afrin Shaikh18 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please refer closure of trading window details attached28 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Please find enclosed financial result for the quarter ended 30th September 20258 Nov 2025 · Result / Financial Results
In continuation of our Letter dated 1st November, 2025 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday, 8th November, 2025 at Shop No ....8 Nov 2025 · Board Meeting / Outcome of Board Meeting
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve Pursuant to Regulation ....2 Nov 2025 · Board Meeting / Board Meeting
Please refer letter attached under Regulation 74(5).19 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please refer letter attached for the change of management28 Sep 2025 · Company Update / Change in Management
Please refer letter attached for the Change in Management28 Sep 2025 · Company Update / Change in Management
Please Refer Scrutinizer Report Attached28 Sep 2025 · AGM/EGM / AGM
Please Refer letter attached for AGM proceeding held on 27th September 2025 at 3.00 pm.27 Sep 2025 · AGM/EGM / AGM
Please refer attached letter on closure of trading window for the quarter ended September 2025.24 Sep 2025 · Insider Trading / SAST / Closure of Trading Window
Kindly refer letter attached along with the intimation of book closure5 Sep 2025 · Corp. Action / Book Closure
With reference to captioned subject find enclosed herewith Annual Report of the Company for the F.Y. 2024-25 Kindly take the same on your record.5 Sep 2025 · Others / Reg. 34 (1) Annual Report
This is to inform you that 18th Annual general meeting is schedule to be held on 27th September 2025 at 3.00 pm through VC/OAVM. Kindly refer to the letter attached for your reference5 Sep 2025 · AGM/EGM / AGM

Board meetings

13 Aug 2026 Board Meeting - Financial Results